On September 26, 2024, the Food and Drug Administration (FDA) approved the first new drug to treat schizophrenia in 35 years. The drug is branded as Cobenfy. It was developed...
The post FDA Approves New Schizophrenia Drug, Cobenfy, Developed By Karuna Therapeutics appeared first on OPEN MINDS.